0001209191-22-051953.txt : 20221003
0001209191-22-051953.hdr.sgml : 20221003
20221003183441
ACCESSION NUMBER: 0001209191-22-051953
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220929
FILED AS OF DATE: 20221003
DATE AS OF CHANGE: 20221003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Scott Andrew
CENTRAL INDEX KEY: 0001614975
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39488
FILM NUMBER: 221289003
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apexigen, Inc.
CENTRAL INDEX KEY: 0001814140
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851260244
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 SHOREWAY ROAD, SUITE C
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650.931.6236
MAIL ADDRESS:
STREET 1: 75 SHOREWAY ROAD, SUITE C
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
FORMER COMPANY:
FORMER CONFORMED NAME: Brookline Capital Acquisition Corp.
DATE OF NAME CHANGE: 20200603
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-09-29
0
0001814140
Apexigen, Inc.
APGN
0001614975
Smith Scott Andrew
C/O APEXIGEN, INC.
75 SHOREWAY ROAD, SUITE C
SAN CARLOS
CA
94070
1
0
0
0
Stock Option (right to buy)
2.65
2022-09-29
4
A
0
100000
0.00
A
2032-09-29
Common Stock
100000
100000
D
The shares subject to the option vest in three equal annual installments beginning on July 29, 2023.
/s/ Francis Sarena, by power of attorney
2022-10-03